← Back to catalogue

Bd Max™ Mrsa Xt

FDA UDI

Class II (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD MAX™ MRSA XT FDA UDI
Generic Name
MRSA nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
BD MAX™ MRSA XT FDA UDI
Model / Reference
443461 FDA UDI
Description
BD MAX™ MRSA XT FDA UDI

Identifiers

Catalog Number
443461 FDA UDI
Primary DI / UDI-DI
00382904434618 FDA UDI
510(k) Number
K133605 FDA UDI
FDA Product Code
NQX FDA UDI
OOI FDA UDI
GMDN Term
MRSA nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.1640 FDA UDI
862.2570 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: MRSA nucleic acid IVD, kit, nucleic acid technique (NAT)

Bd Max™ Mrsa Xt by Becton Dickinson And Company — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as MRSA nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Becton Dickinson And Company

Sources (1)

  • FDA UDI 36749d0b-7509-4014-b909-273c192f6101 37 fields · synced May 31, 2026